AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 65 filers reported holding AVROBIO INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,000 | +50.0% | 1,979 | -14.9% | 0.00% | – |
Q2 2023 | $2,000 | 0.0% | 2,325 | +24.7% | 0.00% | – |
Q1 2023 | $2,000 | +100.0% | 1,865 | 0.0% | 0.00% | – |
Q4 2022 | $1,000 | 0.0% | 1,865 | -17.4% | 0.00% | – |
Q3 2022 | $1,000 | -50.0% | 2,257 | +15.4% | 0.00% | – |
Q2 2022 | $2,000 | -60.0% | 1,955 | -53.4% | 0.00% | – |
Q1 2022 | $5,000 | -86.1% | 4,192 | -55.6% | 0.00% | – |
Q4 2021 | $36,000 | +12.5% | 9,440 | +61.6% | 0.00% | – |
Q3 2021 | $32,000 | -99.6% | 5,843 | -99.3% | 0.00% | -100.0% |
Q2 2021 | $7,455,000 | +13454.5% | 838,548 | +19519.7% | 0.00% | – |
Q1 2021 | $55,000 | +96.4% | 4,274 | +112.4% | 0.00% | – |
Q4 2020 | $28,000 | +16.7% | 2,012 | +7.9% | 0.00% | – |
Q3 2020 | $24,000 | -29.4% | 1,865 | -2.6% | 0.00% | – |
Q2 2020 | $34,000 | +9.7% | 1,914 | -3.3% | 0.00% | – |
Q1 2020 | $31,000 | +10.7% | 1,979 | +43.3% | 0.00% | – |
Q4 2019 | $28,000 | +2700.0% | 1,381 | +2024.6% | 0.00% | – |
Q4 2018 | $1,000 | -83.3% | 65 | -48.0% | 0.00% | – |
Q3 2018 | $6,000 | – | 125 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,417,204 | $28,528,000 | 17.28% |
Aisling Capital Management LP | 893,079 | $17,978,000 | 6.89% |
AlpInvest Partners B.V. | 200,732 | $4,041,000 | 3.44% |
TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $20,130,000 | 2.40% |
New Leaf Venture Partners, L.L.C. | 315,550 | $6,352,000 | 1.38% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,164,970 | $23,451,000 | 0.75% |
Eventide Asset Management | 1,305,307 | $26,276,000 | 0.74% |
Camber Capital Management LP | 600,000 | $12,078,000 | 0.62% |
EMERALD ADVISERS, LLC | 656,306 | $13,211,000 | 0.56% |
EMERALD MUTUAL FUND ADVISERS TRUST | 641,387 | $12,911,000 | 0.53% |